Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses
Proceedings of the National Academy of Sciences (2013)
REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors.
Investigational new drugs (2012)
Filamentous Influenza Virus Enters Cells Via Macropinocytosis.
Journal of virology (2012)
Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients
Science Translational Medicine (2012)